Advanced search
Publication Cover
Leukemia & Lymphoma Volume 51, 2010 - Issue 6
Submit an article Journal homepage
238
Views
12
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Mutations in ABL kinase domain are associated with inferior progression-free survival

Pratibha SharmaDepartment of Medical Oncology, Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India
,
Sujata MohantyDepartment of Medical Oncology, Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India
,
Vinod KochupillaiDepartment of Medical Oncology, Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India
&
Lalit KumarDepartment of Medical Oncology, Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, IndiaCorrespondence[email protected]
Pages 1072-1078 | Received 13 Nov 2009, Accepted 23 Feb 2010, Published online: 01 Apr 2010

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Naranie Shanmuganathan, Devendra Keshaorao Hiwase & David Morrall Ross. (2017) Treatment of chronic myeloid leukemia: assessing risk, monitoring response, and optimizing outcome. Leukemia & Lymphoma 58:12, pages 2799-2810.
Read now
Adriana Zámečníkova. (2014) Novel approaches to the development of tyrosine kinase inhibitors and their role in the fight against cancer. Expert Opinion on Drug Discovery 9:1, pages 77-92.
Read now
Raquel M. Bengió, Maria E. Riva, Beatriz Moiraghi, Emilio Lanari, Jorge Milone, Veronica Ventriglia, Eduardo Bullorsky, Miguel de Tezanos pinto, Hector Murro, Michele Bianchini & Irene Larripa. (2011) Clinical outcome of chronic myeloid leukemia imatinib-resistant patients: do BCR–ABL kinase domain mutations affect patient survival? First multicenter Argentinean study. Leukemia & Lymphoma 52:9, pages 1720-1726.
Read now

Articles from other publishers (9)

Atreye Majumdar, Rahul Katara, Avshesh Mishra, Aastha Gupta, Deepak K. Sharma, Aman K. Srivastava, Shivani Sharma, Ankita Jaiswal, Mallika Dixit, Vipin Kumar, Sachin Kumar, Varun Kumar, Rahul Sharma & Sambit K. Mohanty. (2022) A Retrospective Analysis of BCR-ABL1 Kinase Domain Mutations in the Frontline Drug Intolerant or Resistant Chronic Myeloid Leukemia Patients: An Indian Experience from a High-End Referral Laboratory. South Asian Journal of Cancer.
Crossref
Simona Soverini, Elisabetta Abruzzese, Monica Bocchia, Massimiliano Bonifacio, Sara Galimberti, Antonella Gozzini, Alessandra Iurlo, Luigiana Luciano, Patrizia Pregno, Gianantonio Rosti, Giuseppe Saglio, Fabio Stagno, Mario Tiribelli, Paolo Vigneri, Giovanni Barosi & Massimo Breccia. (2019) Next-generation sequencing for BCR-ABL1 kinase domain mutation testing in patients with chronic myeloid leukemia: a position paper. Journal of Hematology & Oncology 12:1.
Crossref
Prasanth GanesanLalit Kumar. (2017) Chronic Myeloid Leukemia in India. Journal of Global Oncology 3:1, pages 64-71.
Crossref
Golale Rostami, Mohammad Hamid, Majid Yaran, Mohsen Khani & Morteza Karimipoor. (2015) Incidence and clinical importance of BCR-ABL1 mutations in Iranian patients with chronic myeloid leukemia on imatinib. Journal of Human Genetics 60:5, pages 253-258.
Crossref
Simona Soverini, Susan Branford, Franck E. Nicolini, Moshe Talpaz, Michael W.N. Deininger, Giovanni Martinelli, Martin C. Müller, Jerald P. Radich & Neil P. Shah. (2014) Implications of BCR-ABL1 kinase domain-mediated resistance in chronic myeloid leukemia. Leukemia Research 38:1, pages 10-20.
Crossref
Silvia Marcé, Lurdes Zamora, Marta Cabezón, Blanca Xicoy, Concha Boqué, Cristalina Fernández, Javier Grau, José-Tomás Navarro, Alberto Fernández de Sevilla, Josep-Maria Ribera, Evarist Feliu & Fuensanta Millá. (2013) Frequency of ABL gene mutations in chronic myeloid leukemia patients resistant to imatinib and results of treatment switch to second-generation tyrosine kinase inhibitors. Medicina Clínica 141:3, pages 95-99.
Crossref
Lee-Yung Shih, Ming-Chung Kuo, Ching-Yuan Kuo, Tseng-Hsi Lin, Li-Yaun Bai, Tsai-Yun Chen, Ming-Chung Wang, Tung-Liang Lin, Yii-Jenq Lan, Chih-Cheng Chen, Youngsen Yang, Pei-Ching Hsiao, Chang-Liang Lai, Chia-Hui Chang & Tung-Huei Lin. (2013) Emerging kinetics of BCR–ABL1 mutations and their effect on disease outcomes in chronic myeloid leukemia patients with imatinib failure. Leukemia Research 37:1, pages 43-49.
Crossref
S. Preuner, G. Mitterbauer, C. Mannhalter, S. Herndlhofer, W.R. Sperr, P. Valent & T. Lion. (2012) Quantitative monitoring of BCR/ABL1 mutants for surveillance of subclone-evolution, -expansion, and -depletion in chronic myeloid leukaemia. European Journal of Cancer 48:2, pages 233-236.
Crossref
Yi-fan Chen & Li-wu Fu. (2011) Mechanisms of acquired resistance to tyrosine kinase inhibitors. Acta Pharmaceutica Sinica B 1:4, pages 197-207.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.